Lifecare ASA - Director's Dealing 2023

Mandatory notification of trade

Bergen, Norway 3 November 2023: Reference is made to stock exchange

notification 1 June 2022 with notification of trade of 25 000 shares by

primary insider Joacim Holter. Enclosed to the stock exchange notification was

a KRT 1500 form informing that the shares was planned to be transferred to

Joacim Holters children.

Today, Lifecare has received notification that Joacim Holter accordingly has

transferred a total of 24 999 shares to his closely related parties;

* Ingrid Holter (8 333 shares),

* Julie Holter, (8 333 shares),

* Fredrik Holter, (8 333 shares),

for a price of 3,00 NOK per share.

After the transfer, Joacim Holter holds a total of 292 998 shares in Lifecare

AS, as well as 1 331 355 shares through his fully owned investment company

Cimter AS, 1 331 355 shares.

About us

Lifecare AS is a clinical stage medical sensor company developing technology

for sensing and monitoring of various body analytes. Lifecare's main focus is

to bring the next generation of Continuous Glucose Monitoring ("CGM") systems

to market. Lifecare enables osmotic pressure as sensing principle, combined

with the ability to manipulate Nano-granular Tunnelling Resistive sensors

("NTR") on the sensor body for read-out of pressure variations. Lifecare's

sensor technology is referred to as "Sencell" and is suitable for identifying

and monitoring the occurrence of a wide range of analytes and molecules in the

human body.

Contacts

For further information, please contact:

Joacim Holter, CEO, Lifecare AS, [email protected], +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs,

This information is information that Lifecare AS is obliged to make public

pursuant to the EU Market Abuse Regulation. The information was submitted for

publication, through the agency of the contact persons set out above, at

2023-11-03 18:15 CET.

AI assistant